Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Oral Melatonin to Prevent Necrotizing Enterocolitis in Preterm Infants
NCT05033639Phase 2Completed
- Sponsor
- Ilocos Training and Regional Medical Center
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in necrotizing enterocolitis (NEC), sponsored by Ilocos Training and Regional Medical Center. Started Mar 2021; status: completed.
02
Drugs
melatonin
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT05033639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05033639.